PositiveID Corporation to Exhibit its Caregiver Non-Contact Thermometer at the Health Connect Partners 2017 Spring Hospital Supply Chain Conference

DELRAY BEACH, Fla., Feb. 13, 2017 -- February 13, 2017 – PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that it will exhibit its Caregiver® non-contact, infrared thermometer at the Health Connect Partners (“HCP”) 2017 Spring Hospital Supply Chain Conference at the Hyatt Regency in Miami, FL from February 27–March 1, 2017.

Caregiver is a clinical-grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants without contact. It delivers an oral-equivalent temperature directly from the forehead in one to two seconds without touching the skin. Since Caregiver does not require probe cover supplies, it reduces the risk of cross-contamination and saves healthcare facilities the cost of covers (as much as $0.05 to $0.10 per temperature), storage space, and waste disposal costs. It is estimated that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone.

HCP connects providers and suppliers through educational meetings and conferences to provide the best in healthcare education and networking so providers learn real solutions and suppliers understand their real needs. HCP brings providers and suppliers together through industry-specific conferences, including Hospital Pharmacy, Hospital O.R. & Surgical, Radiology & Imaging, Hospital Supply Chain and Hospital & Healthcare I.T. Each aspect of its conferences is designed to provide the optimum environment for networking and building relationships between providers and suppliers.

PositiveID’s Thermomedics team is featuring Caregiver at the HCP conference to increase exposure and awareness for Caregiver and generate qualified leads for dealer follow-up.

About PositiveID Corporation
PositiveID Corporation is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is also a leader in the specialty vehicle market, with a focus on mobile labs, and markets the Caregiver non-contact thermometer. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.

Statements about PositiveID's future expectations constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company’s ability to target the professional healthcare market, as well as other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on April 12, 2016, and 10-Qs filed on November 18, 2016, August 12, 2016, and May 16, 2016, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Contacts:
PositiveID Corporation
Allison Tomek
(561) 805-8044
[email protected]

RedChip Companies
Jon Cunningham
(407) 644-4256
[email protected]